Publicacións nas que colabora con ANXO VIDAL FIGUEROA (18)

2024

  1. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2046-2061

  2. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors

    Journal of Controlled Release, Vol. 373, pp. 277-292

2023

  1. Matrices Activadas con ARNm como Sistema para la Regeneración de Cartílago Articular

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

    Nature Communications, Vol. 13, Núm. 1

  2. Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer (Nature Communications, (2022), 13, 1, (4829), 10.1038/s41467-022-31859-3)

    Nature Communications

2021

  1. Delivery of transcription factors as modulators of cell differentiation

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 426-444

2020

  1. mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering

    Biomaterials, Vol. 247

2019

  1. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

2017

  1. New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 69-78

2016

  1. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer

    Journal of Controlled Release, Vol. 238, pp. 263-271

  2. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size

    International Journal of Pharmaceutics, Vol. 509, Núm. 1-2, pp. 107-117

  3. Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node

    Journal of Nanobiotechnology, Vol. 14, Núm. 1

2015

  1. HOW REGENERATIVE MEDICINE CAN BENEFIT FROM NUCLEIC ACIDS DELIVERY NANOCARRIERS?

    POLYMERS IN REGENERATIVE MEDICINE: BIOMEDICAL APPLICATIONS FROM NANO- TO MACRO-STRUCTURES (BLACKWELL SCIENCE PUBL), pp. 285-336

2014

  1. How Regenerative Medicine Can Benefit from Nucleic Acids Delivery Nanocarriers?

    Polymers in Regenerative Medicine: Biomedical Applications from Nano- to Macro-Structures (wiley), pp. 285-336

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

  2. Chitosan-based nanomaterials for drug delivery and antibiotic-free bacterial control

    Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013

  3. Polyarginine nanocapsules: A new platform for intracellular drug delivery

    Journal of Nanoparticle Research, Vol. 15, Núm. 3

2008

  1. Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers

    Biomacromolecules, Vol. 9, Núm. 8, pp. 2186-2193